|
1) Ozawa S, Kumai K, Higuchi K, et al. Short-term and long term outcome of endoluminal gastroplication for the treatment of GERD: the first multicenter trial in Japan. J Gastroenterol. 2009; 44: 675-84
|
|
|
|
2) Ozawa S, Yoshida M, Kumai K, et al. New endoscopic treatments for gastroesophageal reflux disease. Ann Thorac Cardiovasc Surg. 2005; 11: 146-53
|
|
|
|
|
|
3) von Renteln D, Schiefke I, Fuchs KH, et al. Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease using multiple plicator implants: 12-month multicenter study results. Surg Endosc. 2009; 23: 1866-75
|
|
|
|
|
|
4) Birk J, Pruitt R, Haber G, et al. The Plicator procedure for the treatment of gastroesophageal reflux disease: a registry study. Surg Endosc. 2009; 23: 423-31
|
|
|
|
|
|
5) Repici A, Fumagalli U, Malesci A, et al. Endoluminal fundoplication (ELF) for GERD using EsophyX: a 12-month follow-up in a single-center experience. J Gastrointest Surg. 2010; 14: 1-6
|
|
|
|
|
|
6) Cadiere GB, Buset M, Muls V, et al. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg. 2008; 32: 1676-88
|
|
|
|
|
|
7) Frazzoni M, Conigliaro R, Manta R, et al. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther. 2011; 34: 67-75
|
|
|
|
|
|
8) Fass R. Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease. Drugs. 2007; 67: 1521-30
|
|
|
|
|
|
9) Anvari M, Allen C, Marshall J, et al. A randomized controlled trial of laparoscopic nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: one-year follow up. Surg Innov. 2006; 13: 238-49
|
|
|
|
|
|
10) Epstein D, Bojke L, Sculpher MJ. REFLUX trial group. Laparoscopicfundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study. BMJ. 2009; 339: 1-7
|
|
|
|
|
|
11) Galmiche JP, Hatlebakk J, Attwood S, et al. LOTUS Trial Collaborators. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011; 305: 1969-77
|
|
|
|
|
|
12) Sakata R, Fujii Y, Kuwano H. Thoracic and cardiovascular in Japan during 2008: Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2010; 58: 356-83
|
|
|
|
|
|
13) Peters MJ, Mukhtar A, Yunus RM, et al. Meta-analysis of randomized clinical trials comparing open and laparoscopic anti-reflux surgery. Am J Gastroenterol. 2009; 104: 1548-61
|
|
|
|
|
|
14) Broeders JA, Rijnhart-de Jong HG, Draaisma WA, et al. Ten-year outcome of laparoscopic and conventional nissen fundoplication: randomized clinical trial. Ann Surg. 2009; 250: 698-706
|
|
|
|
|
|
15) Broeders JA, Mauritz FA, Ahmed Ali U, et al. Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-oesophageal reflux disease. Br J Surg. 2010; 97: 1318-30
|
|
|
|
|
|
16) Shan CX, Zhang W, Zheng XM, et al. Evidence-based appraisal in laparoscopic Nissen and Toupet fundoplications for gastroesophageal reflux disease. World J Gastroenterol. 2010; 16: 3063-71
|
|
|
|
|
|
17) Shaw JM, Bornman PC, Callanan MD, et al. Long-term outcome of laparoscopic Nissen and laparoscopic Toupet fundoplication for gastroesophageal reflux disease: a prospective, randomized trial. Surg Endosc. 2010; 24: 924-32
|
|
|
|
|
|
18) Nijjar RS, Watson DI, Jamieson GG, et al. International Society for the Diseases of the Esophagus-Australasian Section. Five-year follow-up of a multicenter, double-blind randomized clinical trial of laparoscopic Nissen vs anterior 90 degrees partial fundoplication. Arch Surg. 2010; 145: 552-7
|
|
|
|
|
|
19) Khan M, Smythe A, Globe J, et al. Randomized controlled trial of laparoscopic anterior versus posterior fundoplication for gastro-oesophageal reflux disease. ANZ J Surg. 2010; 80: 500-5
|
|
|
|
|
|
20) Mickevicius A, Endzinas Z, Kiudelis M, et al. Influence of wrap length on the effectiveness of Nissen and Toupet fundoplication: a prospective randomized study. Surg Endosc. 2008; 22: 2269-76
|
|
|
|
|
|
21) Tsimogiannis KE, Pappas-Gogos GK, Benetatos N, et al. Laparoscopic Nissen fundoplication combined with posterior gastropexy in surgical treatment of GERD. Surg Endosc. 2010; 24: 1303-9
|
|
|
|
|
|
22) Kösek V, Wykypiel H, Weiss H, et al. Division of the short gastric vessels during laparoscopic Nissen fundoplication: clinical and functional outcome during long-term follow-up in a prospectively randomized trial. Surg Endosc. 2009; 23: 2208-13
|
|
|
|
|
|
23) Mardani J, Lundell L, Lönroth H, et al. Ten-year results of a randomized clinical trial of laparoscopic total fundoplication with or without division of the short gastric vessels. Br J Surg. 2009; 96: 61-5
|
|
|
|
|
|
24) Mi J, Kang Y, Chen X, et al. Whether robot-assisted laparoscopic fundoplication is better for gastroesophageal reflux disease in adults: a systematic review and meta-analysis. Surg Endosc. 2010; 24: 1803-14
|
|
|
|
|
|
25) Markar SR, Karthikesalingam AP, Hagen ME, et al. Robotic vs. laparoscopic Nissen fundoplication for gastro-oesophageal reflux disease: systematic review and meta-analysis. Int J Med Robot. 2010; 6: 125-31
|
|
|
|
|
|
26) Zhang P, Tian JH, Yang KH, et al. Robot-assisted laparoscope fundoplication for gastroesophageal reflux disease: a systematic review of randomized controlled trials. Digestion. 2010; 81: 1-9
|
|
|
|
|
|
27) Zehetner J, Lipham JC, Ayazi S, et al. A simplified technique for intrathoracic stomach repair: laparoscopic fundoplication with Vicryl mesh and BioGlue crural reinforcement. Surg Endosc. 2010; 24: 675-9
|
|
|
|
|
|
28) Merchant AM, Cook MW, Srinivasan J, et al. Comparison between laparoscopic paraesophageal hernia repair with sleeve gastrectomy and paraesophageal hernia repair alone in morbidly obese patients. Am Surg. 2009; 75: 620-5
|
|
|
|
|
|
29) Bonavina L, DeMeester T, Fockens P, et al. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann Surg. 2010; 252: 857-62
|
|
|
|
|
|
30) Koek GH, Sifrim D, Lerut T, et al. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus. Gut. 2008; 57: 1056-64
|
|
|
|
|
|
31) Shaheen NJ, Sharma P, Overrrholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009; 360: 2277-88
|
|
|
|
|
|
32) Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy. 2010; 42: 781-9
|
|
|
|
|
|
33) Lyday WD, Corbett FS, Kuperman DA, et al. Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy. 2010; 42: 272-8
|
|
|
|
|
|
34) Sharma VK, Jae Kim H, Das A, et al. Circumferential and focal ablation of Barrett's esophagus containing dysplasia. Am J Gastroenterol. 2009; 104: 310-7
|
|
|
|
|
|
35) Pouw RE, Wirths K, Eisendrath P, et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol. 2010; 8: 23-9
|
|
|
|
|
|
36) Pouw RE, Seewald S, Gondrie JJ, et al. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients. Gut. 2010; 59: 1169-77
|
|
|
|
|
|
37) Moss A, Bourke MJ, Hourigan LF, et al. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit. Am J Gastroenterol. 2010; 105: 1276-83
|
|
|
|
|
|
38) Overholt BF, Wang KK, Burdick JS, et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc. 2007; 66: 460-8
|
|
|
|
|
|
39) Bronner MP, Overholt BF, Taylor SL, et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology. 2009; 136: 56-64
|
|
|
|
|
|
40) Bright T, Watson DI, Tam W, et al. Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus in patients treated with antisecretory medication. Dig Dis Sci. 2009; 54: 2606-11
|
|
|
|
|
|
41) Dumot JA, Vargo JJ 2nd, Falk GW, et al. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc. 2009; 70: 635-44
|
|
|
|
|
|
42) Greenwald BD, Dumot JA, Horwhat JD, et al. Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus. Dis Esophagus. 2010; 23: 13-9
|
|
|
|
|
|
43) Spechler SJ, Sharma P, Souza RF, et al. American Gastroenterological Association. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology. 2011; 140: e18-52
|
|
|
|
|